Anindita Deb, MD


Advocacy and Empowerment: Finding Your Advocacy Community

The Palatucci Advocacy Leadership Forum, or PALF, sponsored by the American Academy of Neurology, gives neurologists and trainees tools to successfully advocate for their ideas and develop their identity as physician advocates.

Sharon Cohen, MD, FRCPC


Management of Amyloid Related Imaging Abnormalities (ARIA) for Alzheimer’s Disease

Dr Atri comments on observation of amyloid related imaging abnormalities (ARIA) seen with many Alzheimer’s disease treatments and shares his thoughts on management of ARIA.

Nicholas Beimer, MD


Early Awareness Towards Epilepsy Transition

Sucheta M. Joshi, MD, MS, FAES, FAAP, and Nicholas Beimer, MD, discussed the reasons why EpiTRAQ may influence earlier discussions with patients prior to the epilepsy transition process.

Mirla Avila, MD


R&D for NMOSD Therapies

Drs Mirla Avila, Mitzi Williams, Michael Levy, and Michael Yeaman comment on research and development priorities for clinical care and emerging therapies for NMOSD.

R. Scott Turner, MD, PhD, FANA, FAAN


Achieving Greater Diversity in Dementia Research: A Call to Action

Achieving greater diversity in study populations is a focus of increasing scrutiny, priority, and funding in all medical research, including studies enrolling individuals on the continuum of prodromal Alzheimer disease, mild cognitive impairment, and Alzheimer disease.

Erinn E. Beagin, MD


Managing Insomnia: Practical Advice for Community Physicians

Closing their discussion on insomnia, panelists share final thoughts and advice for community physicians.

Timothy Miller, MD, PhD


Future Thoughts and Reason for Excitement in ALS: Timothy Miller, MD, PhD

The codirector of the ALS Center at Washington University School of Medicine detailed the reasons for hope within the ALS space and the promising innovations in the coming future. [WATCH TIME: 4 minutes]

Donald S. Higgins, Jr., MD


AUPN Leadership Minute Episode 9: Engaging Medical Students in Neurology – Part 2

Episode 9 of the AUPN Leadership Minute features Donald S. Higgins, Jr., MD, of the Veterans Health Administration; and Douglas J. Gelb, MD, PhD, of the University of Michigan [WATCH TIME: 5 minutes]

Vamshi K. Rao, MD


Future of Treating DMD

Final thoughts from leading experts on the future of treating Duchenne muscular dystrophy and keeping standard of care in the forefront.

Lawrence Newman, MD


Connections Between Migraine and Mental Health: Lawrence Newman, MD

The chair of the American Migraine Foundation spoke about the insight gleaned from a recent survey the foundation conducted assessing links between mental health and migraine care. [WATCH TIME: 4 minutes]

Gavin Giovannoni, MD


Future of Relapsing MS Management

Key opinion leaders in multiple sclerosis (MS) discuss the future of relapsing MS management and unmet needs.

Evanthia Bernitsas, MD


Understanding Disadvantages to African Americans in NMOSD Trials: Evanthia Bernitsas, MD

The neurologist at Wayne State University provided background on why there needs to be a continued focus on including and studying African American patients with NMOSD in trials. [WATCH TIME 3 minutes]

Robert K. Shin, MD


The State of Multiple Sclerosis Therapy and Trends in Thinking: Robert K. Shin, MD

The professor of neurology at MedStar Georgetown University Hospital shared his perspective on the trends in thinking about the treatment of MS and how an improved understanding of underlying processes has led to a shift in the field. [WATCH TIME: 5 minutes]

Dawn Edhe, PhD


State of Mental Health Care for Patients With MS: Dawn Edhe, PhD

The psychologist and professor in the department of rehabilitation medicine at the University of Washington shared her perspective on the state of mental health care in multiple sclerosis. [WATCH TIME: 4 minutes]

Karin Cook


Questions of Adherence Raised by Unused Multiple Sclerosis Disease-Modifying Therapies: Darin T. Okuda, MD; Karin Cook

The coauthors of a study assessing costs associated with unused disease-modifying therapies shared their insight into the extended effects of unused treatments in MS, including the importance of transparency between physician and patient. [WATCH TIME: 12 minutes]

Renee Shellhaas, MD, MS, FAES


Need for Increased Multidisciplinary Study of Newborn and Infant Sleep in Epilepsy: Renee Shellhaas, MD, MS, FAES

The professor of neurology at Washington University School of Medicine in St. Louis spoke about the field of newborn sleep and epilepsy based on a special lecture from the 2022 AES annual meeting. [WATCH TIME: 3 minutes]

Thomas Wisniewski, MD


Exponential Growth of Research, Biomarkers in Alzheimer Disease: Thomas Wisniewski, MD

The director of NYU Langone’s Alzheimer’s Disease Research Center discussed noticeable advancements within the field of Alzheimer disease in recent years and how they contribute to gaining a better understanding of the disease. [WATCH TIME: 5 minutes]

Jonathan Isaacson, MD


Differentiating Tardive Dyskinesia From Similar Drug-Induced Movement Disorders

Tardive dyskinesia can present many challenges in its treatment and can be difficult to differentiate from similar disorders.

Jefferson Kinney, PhD


Assessing, Validating Clinically Relevant Biomarkers for Alzheimer Disease: Jefferson Kinney, PhD

The founding chair of the department of brain health at the University of Nevada Las Vegas discussed the plethora of Alzheimer disease biomarkers and the need for consensus on the value of each. [WATCH TIME: 3 minutes]

Laurie Gutmann, MD


AUPN 2022 Women Leaders in Neurology

Laurie Gutmann, MD; Gauri Pawar, MD; and Claire Henchcliffe, MD, discuss their own paths in medicine and observations of other women leaders. [WATCH TIME: 1 hour, 51 minutes]

Robert A. Hauser, MD, MBA


Key Takeaways for Treating OFF Episodes in PD

Drs Laxman Bahroo, Rajesh Pahwa, and Robert A. Hauser share advice for neurologists treating OFF episodes in Parkinson Disease.

Paul Fisher, MD


Stanford Children’s Health: A Comprehensive Approach to Care for a Child With a Neurological Condition

Physicians from Stanford Children’s Health offer their keys to successful pediatric neuroscience teams and what to focus on to provide a better quality of life for children.

Chengyuan Wu, MD, MSBmE


Roundtable: The Future of Stereotactic and Functional Neurosurgery

Two experts at Jefferson Health discuss several topics related to advances in neurosurgery, technology, and the future of minimally invasive procedures.

Eric P. Hoffman, PhD


Future of Treating DMD

Final thoughts from leading experts on the future of treating Duchenne muscular dystrophy and keeping standard of care in the forefront.

Marcelo Kerstenetzky, MD


Ideal Patient Profiles for Spinal Muscular Atrophy Therapies / Perfis ideais de pacientes para tratamento da atrofia muscular espinhal

The expert panel comments on ideal patient profiles for SMA treatment with nusinersen, onasemnogene abeparvovec, and risdiplam. O painel de especialistas comenta os perfis ideais de pacientes para tratamento da atrofia muscular espinhal com nusinersena, onasemnogeno abeparvoveque e risdiplam.

Donald Whiting, MD


Exploring Deep Brain Stimulation’s Effects in Alzheimer Disease: Donald Whiting, MD

The chair of Allegheny Health Network’s Neurosciences Institute discussed a groundbreaking phase 3 trial evaluating the safety and efficacy of deep brain stimulation in patients with Alzheimer disease. [WATCH TIME: 5 minutes]

Blake E. Dewey, PhD


Expanding the Use of Spinal Cord Atrophy in Multiple Sclerosis: Blake E. Dewey, PhD

The postdoctoral researcher at the Johns Hopkins Multiple Sclerosis Center shared his perspective on the use of spinal cord atrophy in clinical practice to measure disease progression in MS and how it might become more accessible. [WATCH TIME: 4 minutes]

Theresa Sevilis, DO


Taking the Leap: Forging Your Own Path as a Woman in Medicine

Theresa Sevilis, DO, writes on picking a career path in medicine as a woman, and how deciding to jump ship from a traditional path was among the best decisions she's made.

Jacqueline Glascock, PhD


2022 SMA Research & Clinical Care Meeting: What to Expect

Mary Schroth, MD, and Jacqueline Glascock, PhD, of Cure SMA, share their perspectives on the upcoming annual meeting.

Anne H. Cross, MD


Future Directions in Research and Treatment

Looking to the future of multiple sclerosis care, the panel of thought leaders pose important questions that remain to be answered in the research and treatment of multiple sclerosis.

© 2023 MJH Life Sciences

All rights reserved.